CLINICAL_TRIALS
trial_result
· 2023-09-21
Clinical Trial Update: Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis [Phase 1, Phase 2]
Summary
Safety study results for VM202 in amyotrophic lateral sclerosis (Phase 1/Phase 2) have been completed, and results were posted in September 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Helixmith Co., Ltd. | Conditions: Amyotrophic Lateral Sclerosis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-21